BECN1 and diabetic kidney disease: When 20 mg/kg resveratrol is used to interfere with diabetic nephropathy rat models, the autophagy markers Beclin-1 and LC3II in the resveratrol group were found significantly increased, while the creatinine clearance rate and 24 h urine protein quantification were decreased.